Atrion Corp ATRI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATRI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $399.83
- Day Range
- $401.50–419.19
- 52-Week Range
- $274.98–643.48
- Bid/Ask
- $162.90 / $644.41
- Market Cap
- $713.24 Mil
- Volume/Avg
- 39,708 / 20,488
Key Statistics
- Price/Earnings (Normalized)
- 36.74
- Price/Sales
- 4.22
- Dividend Yield (Trailing)
- 2.19%
- Dividend Yield (Forward)
- 2.20%
- Total Yield
- 2.42%
Company Profile
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 712
- Website
- https://www.atrioncorp.com
Comparables
Valuation
|
Metric
|
ATRI
|
MMSI
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | 36.74 | 24.64 | — |
Price/Book Value | 2.94 | 3.57 | 3.66 |
Price/Sales | 4.22 | 3.44 | 4.22 |
Price/Cash Flow | 20.22 | 20.12 | — |
Price/Earnings
ATRI
MMSI
SIBN
Financial Strength
|
Metric
|
ATRI
|
MMSI
|
SIBN
|
|---|---|---|---|
Quick Ratio | 2.32 | 3.81 | 8.01 |
Current Ratio | 9.09 | 5.45 | 9.01 |
Interest Coverage | 145.76 | 8.07 | −13.52 |
Quick Ratio
ATRI
MMSI
SIBN
Profitability
|
Metric
|
ATRI
|
MMSI
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | 8.16% | 9.43% | −8.97% |
Return on Equity (Normalized) | 8.95% | 14.77% | −12.61% |
Return on Invested Capital (Normalized) | 8.65% | 11.47% | −11.78% |
Return on Assets
ATRI
MMSI
SIBN
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Xpzbdpbkc | Rxgf | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Hrtmdwq | Lfktlzy | $67.6 Bil | |
ALC
| Alcon Inc | Wsfthytd | Kkswp | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Kppgrrclw | Blxb | $29.4 Bil | |
WST
| West Pharmaceutical Services Inc | Nmntkxkbq | Jbbk | $28.6 Bil | |
RMD
| ResMed Inc | Jrwnzlkj | Dwcvt | $27.1 Bil | |
BAX
| Baxter International Inc | Mchjmzrb | Tvgkfy | $20.9 Bil | |
COO
| The Cooper Companies Inc | Lrklzjkh | Ztdvj | $18.2 Bil | |
HOLX
| Hologic Inc | Qwjxpcls | Jjtvpqp | $17.9 Bil | |
TFX
| Teleflex Inc | Jlkxm | Zxcb | $9.9 Bil |